Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYD Dengue Vaccine Safety and Immunogenicity in Singapore (CYD28)
NCT00880893Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2009
- Primary completion
- Oct 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CYD-TDV in dengue fever, sponsored by Sanofi. Started Apr 2009; status: completed.
02
Drugs
CYD-TDV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT00880893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880893.